Cargando…
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
The recent corona virus disease (COVID-19) outbreak has claimed the lives of many around the world and highlighted an urgent need for experimental strategies to prevent, treat and eradicate the virus. COVID-19, an infectious disease caused by a novel corona virus and no approved specific treatment i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443335/ https://www.ncbi.nlm.nih.gov/pubmed/32846164 http://dx.doi.org/10.1016/j.lfs.2020.118336 |
_version_ | 1783573614943010816 |
---|---|
author | Bhavana, Valamla Thakor, Pradip Singh, Shashi Bala Mehra, Neelesh Kumar |
author_facet | Bhavana, Valamla Thakor, Pradip Singh, Shashi Bala Mehra, Neelesh Kumar |
author_sort | Bhavana, Valamla |
collection | PubMed |
description | The recent corona virus disease (COVID-19) outbreak has claimed the lives of many around the world and highlighted an urgent need for experimental strategies to prevent, treat and eradicate the virus. COVID-19, an infectious disease caused by a novel corona virus and no approved specific treatment is available yet. A vast number of promising antiviral treatments involving nanotechnology are currently under investigation to aid in the development of COVID-19 drug delivery. The prospective treatment options integrating the ever-expanding field of nanotechnology have been compiled, with the objective to show that these can be potentially developed for COVID-19 treatment. This review summarized the current state of knowledge, research priorities regarding the pandemic and post COVID-19. We also focus on the possible nanotechnology approaches that have proven to be successful against other viruses and the research agenda to combat COVID-19. |
format | Online Article Text |
id | pubmed-7443335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74433352020-08-24 COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic Bhavana, Valamla Thakor, Pradip Singh, Shashi Bala Mehra, Neelesh Kumar Life Sci Article The recent corona virus disease (COVID-19) outbreak has claimed the lives of many around the world and highlighted an urgent need for experimental strategies to prevent, treat and eradicate the virus. COVID-19, an infectious disease caused by a novel corona virus and no approved specific treatment is available yet. A vast number of promising antiviral treatments involving nanotechnology are currently under investigation to aid in the development of COVID-19 drug delivery. The prospective treatment options integrating the ever-expanding field of nanotechnology have been compiled, with the objective to show that these can be potentially developed for COVID-19 treatment. This review summarized the current state of knowledge, research priorities regarding the pandemic and post COVID-19. We also focus on the possible nanotechnology approaches that have proven to be successful against other viruses and the research agenda to combat COVID-19. Elsevier Inc. 2020-11-15 2020-08-23 /pmc/articles/PMC7443335/ /pubmed/32846164 http://dx.doi.org/10.1016/j.lfs.2020.118336 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bhavana, Valamla Thakor, Pradip Singh, Shashi Bala Mehra, Neelesh Kumar COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic |
title | COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic |
title_full | COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic |
title_fullStr | COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic |
title_full_unstemmed | COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic |
title_short | COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic |
title_sort | covid-19: pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the sars-cov2 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443335/ https://www.ncbi.nlm.nih.gov/pubmed/32846164 http://dx.doi.org/10.1016/j.lfs.2020.118336 |
work_keys_str_mv | AT bhavanavalamla covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic AT thakorpradip covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic AT singhshashibala covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic AT mehraneeleshkumar covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic |